However, the mutation might alter downstream signaling (e.g. STAT3, JAK2), surface expression, or receptor trafficking [44–46], which might partly underlie the mechanisms for worse pathological grade and prognosis of PCa in the present study. This evidence concerns the gene JAK2 and posterior cortical atrophy.